← Leaderboards
Michinari Nakamura
Rbhs-New Jersey Medical School
$1,570,000
Attributed
$1,570,000
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $392.5K · FY2021–24$500K$375K$250K$125K$0
'21
'22
'23
'24
Funding mix
By agency
NIH$1,570,000 · 1
By mechanism
R01$1,570,000 · 1
Top collaborators
No co-investigators on record.
Others in their field
Other Emerging Leaders on “Acetylation”
- Michael-Christopher Keogh · Epicypher, Inc.$6,471,083
- Carla Nasca · New York University School Of Medicine$5,293,907
- Srikanth Singamsetty · Phoenix Nest, Inc.$5,047,122
- Stephen Naylor · Reneurogen, Llc$4,526,304
- Christina Woo · Harvard University$4,291,251
- Timothee Lionnet · New York University School Of Medicine$3,899,622
Research focus
AcetylationAnabolismAttenuatedAcetyltransferaseBindingBiological ProcessCaloriesCarbohydratesCardiacCardiac MyocytesCardioprotectionCell NucleusDeprivationDietDietary ComponentEpigenetic ProcessExperimental StudyFastingFatty AcidsFutureGene DeliveryGenomicsGlucoseHeart
Grant awards (4)
Lysine Acetyltransferase 6A in Health and Cardiac Diseases$392,500
R01 · FY2024 · HL · contact PI
Lysine Acetyltransferase 6A in Health and Cardiac Diseases$392,500
R01 · FY2023 · HL · contact PI
Lysine Acetyltransferase 6A in Health and Cardiac Diseases$392,500
R01 · FY2022 · HL · contact PI
Lysine Acetyltransferase 6A in Health and Cardiac Diseases$392,500
R01 · FY2021 · HL · contact PI